Connected profileMaridebart cafraglutide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
AMG 133 clinical trials
6 selected ClinicalTrials.gov records carrying the official matched intervention AMG 133 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
6 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 4 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT07575399
PeptideScanner retained ClinicalTrials.gov record NCT07575399 at 2026-09-09T19:17:17.083Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- August 27, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT07684144
PeptideScanner retained ClinicalTrials.gov record NCT07684144 at 2026-09-09T19:17:17.403Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- September 3, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT07313761
PeptideScanner retained ClinicalTrials.gov record NCT07313761 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- August 7, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Maridebart cafraglutide · 2026-09-03
ClinicalTrials.gov record NCT07684144
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-27
ClinicalTrials.gov record NCT07575399
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-07
ClinicalTrials.gov record NCT07313761
Completed at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-04
ClinicalTrials.gov record NCT07684235
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-07-24
ClinicalTrials.gov record NCT07037433
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-07-02
ClinicalTrials.gov record NCT07037459
Recruiting at the retained observation.
Open attributed record →